AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 177 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $14,834,000 | -45.8% | 1,119,598 | -24.6% | 0.02% | -48.9% |
Q3 2017 | $27,377,000 | -11.3% | 1,483,898 | -11.6% | 0.04% | -18.2% |
Q2 2017 | $30,876,000 | -18.7% | 1,678,098 | -0.4% | 0.06% | -20.3% |
Q1 2017 | $37,998,000 | -13.2% | 1,685,098 | +34.0% | 0.07% | -14.8% |
Q4 2016 | $43,773,000 | +370.8% | 1,257,860 | +231.6% | 0.08% | +350.0% |
Q3 2016 | $9,297,000 | +44.6% | 379,337 | +41.1% | 0.02% | +38.5% |
Q2 2016 | $6,430,000 | +175.8% | 268,837 | +169.8% | 0.01% | +160.0% |
Q1 2016 | $2,331,000 | -17.7% | 99,642 | +6.2% | 0.01% | -16.7% |
Q4 2015 | $2,833,000 | -8.8% | 93,842 | +19.9% | 0.01% | -14.3% |
Q3 2015 | $3,108,000 | – | 78,242 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |